Literature DB >> 21253746

[Pharmacological treatment of nystagmus].

C Pieh-Beisse1, W A Lagrèze.   

Abstract

Nystagmus can be associated with strong discomfort due to oscillopsia, blurry vision and dizziness. Since generally no curative treatment methods exist, studies focus on potential pharmaceuticals to dampen the nystagmus. An overview is given on which forms of nystagmus can be treated with what kind of pharmacological substances and their possible mechanism of nystagmus dampening. Controlled studies found gabapentin and memantine to be effective in acquired pendular nystagmus and early-onset idiopathic nystagmus, and an efficacy of 4-aminopyridine in downbeat nystagmus.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21253746     DOI: 10.1007/s00347-010-2324-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  22 in total

1.  4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.

Authors:  R Kalla; S Glasauer; F Schautzer; N Lehnen; U Büttner; M Strupp; T Brandt
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

2.  Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.

Authors:  Stefan Glasauer; Michael Strupp; Roger Kalla; Ulrich Büttner; Thomas Brandt
Journal:  Ann N Y Acad Sci       Date:  2005-04       Impact factor: 5.691

3.  The use of clonazepam in the treatment of nystagmus-induced oscillopsia.

Authors:  J N Currie; V Matsuo
Journal:  Ophthalmology       Date:  1986-07       Impact factor: 12.079

4.  The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus.

Authors:  M Dieterich; A Straube; T Brandt; W Paulus; U Büttner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

5.  Memantine induces reversible neurologic impairment in patients with MS.

Authors:  P Villoslada; G Arrondo; J Sepulcre; M Alegre; J Artieda
Journal:  Neurology       Date:  2008-12-17       Impact factor: 9.910

6.  Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.

Authors:  M Strupp; O Schüler; S Krafczyk; K Jahn; F Schautzer; U Büttner; T Brandt
Journal:  Neurology       Date:  2003-07-22       Impact factor: 9.910

7.  Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin.

Authors:  Michaela Starck; Holger Albrecht; Walter Pöllmann; Marianne Dieterich; Andreas Straube
Journal:  J Neurol       Date:  2009-09-13       Impact factor: 4.849

8.  Medical treatment of nystagmus and ocular motor disorders.

Authors:  T J Carlow
Journal:  Int Ophthalmol Clin       Date:  1986

9.  The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study.

Authors:  T Shery; F A Proudlock; N Sarvananthan; R J McLean; I Gottlob
Journal:  Br J Ophthalmol       Date:  2006-03-23       Impact factor: 4.638

10.  Treatment of periodic alternating nystagmus.

Authors:  G M Halmagyi; P Rudge; M A Gresty; R J Leigh; D S Zee
Journal:  Ann Neurol       Date:  1980-12       Impact factor: 10.422

View more
  1 in total

1.  [Oculomotor system and multiple sclerosis].

Authors:  A E Höh; C Beisse
Journal:  Ophthalmologe       Date:  2014-08       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.